SUB-ADVISORY AGREEMENTSub-Advisory Agreement • October 4th, 2019 • Delaware Vip Trust
AGREEMENT made by and between DELAWARE MANAGEMENT COMPANY, a series of Macquarie Investment Management Business Trust, a Delaware statutory trust (the “Investment Manager”), and ZIEGLER CAPITAL MANAGEMENT, LLC (the “Sub-Adviser’’).
AMENDMENT NO. 4 TO EXHIBIT A OF THE INVESTMENT MANAGEMENT AGREEMENTInvestment Management Agreement • October 4th, 2019 • Delaware Vip Trust
THIS EXHIBIT to the Investment Management Agreement dated January 4, 2010 (the “Agreement”) between DELAWARE VIP TRUST® and DELAWARE MANAGEMENT COMPANY, a series of Macquarie Investment Management Business Trust (the “Investment Manager”), amended as of the 19th day of July, 2019, lists the Funds for which the Investment Manager provides investment management services pursuant to this Agreement, along with the management fee rate schedule for each Fund and the date on which the Agreement became effective for each Fund.
AMENDMENT NO. 3 TO SCHEDULE I TO THE DISTRIBUTION AGREEMENT AS OF JULY 19, 2019Distribution Agreement • October 4th, 2019 • Delaware Vip Trust
This Schedule to the Distribution Agreement between Delaware VIP Trust and Delaware Distributors, L.P. originally entered into as of May 20, 2003 and amended and restated on January 4, 2010 (the “Agreement”) lists the Series and Classes for which Delaware Distributors, L.P. provides distribution services pursuant to this Agreement, along with the 12b-1 Plan rates, if applicable, for each class and the date on which the Agreement became effective for each Class.
Delaware Management Company 2005 Market Street Philadelphia, PA 19103Delaware Vip Trust • October 4th, 2019
By our execution of this letter agreement (the "Agreement"), intending to be legally bound hereby, Delaware Management Company, a series of Macquarie Investment Management Business Trust (the “Manager”), agrees that in order to improve the performance of the series of Delaware VIP Trust set forth below (each a “Series”), the Manager shall waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding any acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations (collectively, the “Excluded Expenses”)) in an aggregate amount equal to the amount by which the Series’ total annual series operating expenses (excluding any Excluded Expenses) exceed the percentages set forth below for the period from October 4, 2019 through Oc
